股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年12月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 新濠國際發展有限公司 呈交日期: 2026年1月6日 I. 法定/註冊股本變動 不適用 FF301 第 1 頁 共 10 頁 v 1.1.1 FF301 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00200 | 說明 | 不適用 | | | | | | | | 已發行股份（不包括庫存股份）數目 | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | 2,275,025,632 | | | | 2,275,025,632 | | 增加 / 減少 (-) | | | 0 | | | | | | 本月底結存 | | | 2,275,025,632 | | 0 | | 2,275,025, ...

Group 1 - The core point of the article highlights that southbound funds reduced their holdings in Melco International Development (00200.HK) by 1.159 million shares on January 5 [1] - Over the past five trading days, there were four days of net increases in holdings by southbound funds, totaling a net increase of 0.865 million shares [1] - In the last twenty trading days, there were thirteen days of net increases, with a cumulative net increase of 3.8255 million shares [1] Group 2 - As of now, southbound funds hold 14.5 million shares of Melco International Development, representing 6.37% of the company's total issued ordinary shares [1] - Melco International Development Limited primarily engages in entertainment and hotel businesses through two segments: the entertainment and hotel segment, and the investment segment [1] - The entertainment and hotel segment operates casinos and provides hotel services and facilities, including gaming, accommodation, dining, entertainment performances, shopping, and conference exhibition services [1]

Core Viewpoint - Jiangsu Wuzhong (600200) is set to be delisted on December 31, 2025, due to ongoing legal issues related to false statements made by the company, prompting investors to seek compensation for their losses [1][4]. Group 1: Legal Proceedings - The law firm Shanghai Jiucheng has submitted a claim for investor compensation to the Suzhou Intermediate People's Court, with ongoing efforts to accept additional claims from affected investors [1][4]. - Investors who purchased Jiangsu Wuzhong shares between April 20, 2019, and February 27, 2025, and sold or continued to hold them after February 27, 2025, are eligible to initiate claims [6]. Group 2: Regulatory Violations - Jiangsu Wuzhong has been found guilty of failing to disclose its actual controller accurately, with false records in annual reports from 2018 to 2023 [4][5]. - The company inflated its operating revenue, costs, and profits from 2020 to 2023 through non-substantive trade activities with related companies, resulting in significant discrepancies in reported figures [2][5]. - The inflated operating revenues were reported as follows: 494.26 million yuan (26.46%), 468.51 million yuan (26.39%), 430.75 million yuan (21.26%), and 376.66 million yuan (16.82%) for the respective years [2][5]. - The inflated operating costs were reported as 480.68 million yuan (37.08%), 448.24 million yuan (35.47%), 410.82 million yuan (28.40%), and 355.44 million yuan (20.95%) [2][5]. - The inflated total profits were reported as 14.58 million yuan (2.89%), 20.27 million yuan (51.65%), 19.92 million yuan (26.42%), and 21.22 million yuan (29.81%) [2][5]. - There were also significant omissions regarding the disclosure of non-operating fund usage by related parties in annual reports from 2020 to 2023 [3][6].

Core Viewpoint - The company Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. (stock code: *ST Suwu) is set to be delisted from the Shanghai Stock Exchange, with the delisting process commencing on December 9, 2025, and concluding on December 31, 2025 [1][5]. Group 1: Delisting Process - The company's stock will enter a delisting transition period for 15 trading days, after which it will be officially delisted [1]. - Following the delisting, the company's stock will be transferred to the National Equities Exchange and Quotations (NEEQ) system for trading, managed by a designated securities company [2]. Group 2: Financial Misconduct - The company has been penalized for failing to disclose its actual controller and for falsifying financial reports from 2018 to 2023, including inflated revenue and profits [5]. - Specific financial discrepancies include inflated revenues of 49.53 million, 46.85 million, 43.07 million, and 37.67 million for the years 2020 to 2023, representing 26.46%, 26.39%, 21.26%, and 16.82% of reported revenues respectively [6]. - The company also failed to disclose significant non-operating fund occupations by related parties, with balances reaching 169.26 million by the end of 2023, which constituted 96.09% of the reported net assets [7].

Core Viewpoint - The company Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. (ST Wuzhong) will be delisted from the Shanghai Stock Exchange on December 31, 2025, following a trading period of 15 days after the announcement of its delisting [1][5]. Group 1: Delisting Process - The company's stock will enter a delisting transition period starting December 9, 2025, and will be officially delisted on December 31, 2025 [1]. - After delisting, the company's shares will be transferred to the National Equities Exchange and Quotations (NEEQ) system for trading, managed by a designated broker [2]. Group 2: Financial Misconduct - The company was found to have significant financial discrepancies, including failing to disclose the actual controller and falsifying financial reports from 2018 to 2023 [5]. - The company inflated its operating income and costs, with reported inflated figures of 495.26 million yuan, 468.51 million yuan, 430.75 million yuan, and 376.66 million yuan for the years 2020 to 2023, respectively [6]. - The inflated profits for the same years were reported as 14.58 million yuan, 20.27 million yuan, 19.92 million yuan, and 21.22 million yuan, representing significant percentages of the total reported profits [6]. Group 3: Related Party Transactions - The company engaged in non-commercial trade activities with related parties, leading to significant non-operational fund occupation, which was not disclosed in financial reports from 2020 to 2023 [7]. - The balance of non-operational funds occupied by related parties reached 169.26 million yuan by the end of 2023, constituting 96.09% of the company's net assets [7].

Core Viewpoint - The equity change announced by ST Dehao (002005.SZ) is due to the expiration of the "Joint Action Agreement" signed by several shareholders, which will not affect the company's control or governance structure [1] Group 1: Equity Change Details - The equity change involves shareholders including Anhui Dehao Runda Electric Co., Ltd., Bengbu Xinrui Project Management Co., Ltd., Wang Sheng, Beijing Fengyan Private Fund Management Co., Ltd., Beijing Lingrui Investment Management Co., Ltd., and Beijing Lingrui Yixin Asset Management Co., Ltd. [1] - The expiration of the agreement on June 21, 2024, does not involve changes in the number or proportion of shares held by these shareholders [1] Group 2: Impact on Company Structure - The equity change will not lead to a change in the company's control [1] - There are no arrangements to circumvent reduction restrictions or other regulatory requirements [1] - The company's operational development and governance structure will not be adversely affected, and there is no change in the situation of having no controlling shareholder or actual controller [1]

Group 1 - The core point of the news is that Southbound funds have increased their holdings in Melco International Development (00200.HK) by 1.57 million shares on December 17, 2025, marking a net increase of 2.67 million shares over the past five trading days and 6.57 million shares over the last 20 trading days [1][2] - As of now, Southbound funds hold 14.5 million shares of Melco International Development, which accounts for 6.35% of the company's total issued ordinary shares [1][2] - The company primarily engages in entertainment and hotel operations, providing services such as gaming, accommodation, dining, entertainment performances, shopping, and conference exhibitions through its integrated resort business [2]

Group 1 - The core viewpoint of the article highlights that southbound funds have increased their holdings in Melco International Development (00200.HK) by 488,000 shares on December 11, indicating a positive trend in investor interest [1] - Over the past five trading days, there have been four days of net increases in holdings by southbound funds, totaling 1.5715 million shares [1] - In the last twenty trading days, there were twelve days of net increases, amounting to 6.786 million shares [1] Group 2 - As of now, southbound funds hold 14.3 million shares of Melco International Development, which represents 6.26% of the company's total issued ordinary shares [1] - Melco International Development Limited primarily engages in entertainment and hotel operations through two segments: the entertainment and hotel segment, and the investment segment [1] - The entertainment and hotel segment operates integrated resort businesses, including gaming, accommodation, dining, entertainment performances, shopping, and conference exhibitions [1]

Core Viewpoint - The news highlights the significant financial misconduct of Jiangsu Wuzhong (ST Suwu), leading to its delisting from the Shanghai Stock Exchange due to serious violations of disclosure regulations and financial fraud [4][6]. Group 1: Company Misconduct - Jiangsu Wuzhong has been found to have failed to disclose its actual controlling shareholder for several years, leading to a lack of transparency [6]. - The company engaged in financial fraud from 2020 to 2023, inflating its revenue by a total of 1.771 billion yuan and profits by 75.9975 million yuan through non-commercial trade activities with related parties [6]. - As of the end of 2023, the non-operating funds occupied by related parties amounted to 1.693 billion yuan, representing 96.09% of the disclosed net assets [6]. Group 2: Regulatory Actions - The China Securities Regulatory Commission (CSRC) issued an administrative penalty decision against Jiangsu Wuzhong and its executives, imposing a total fine of 30.5 million yuan [8]. - Key executives, including Qian Qunshan, who held multiple leadership roles, were found primarily responsible for the financial misconduct and will face a 10-year ban from the securities market [8]. - The CSRC rejected Jiangsu Wuzhong's defense regarding the nature of its trade activities, affirming that the transactions lacked commercial substance and were designed to obscure the misuse of funds [8].

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年11月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 新濠國際發展有限公司 呈交日期: 2025年12月4日 I. 法定/註冊股本變動 不適用 FF301 第 1 頁 共 10 頁 v 1.1.1 FF301 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00200 | 說明 | 不適用 | | | | | | | | 已發行股份（不包括庫存股份）數目 | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | 2,275,025,632 | | | | 2,275,025,632 | | 增加 / 減少 (-) | | | 0 | | | | | | 本月底結存 | | | 2,275,025,632 | | 0 | | 2,275,025 ...